IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG
Clinical trial NCT01033617 · COMPLETED
Trial details
- NCT number
- NCT01033617
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2014-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.